ArticleERJ open research2023

Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study.

Lavanya Raman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.